Cargando…
Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo
PURPOSE: Based on the continuous exploration of solid tumor immunotherapy, we focused on hepatocellular carcinoma with a high level of morbidity and mortality. We confirm the stability of mcDNA-based CAR T cell generating platform, and investigate the antitumor activity of CD44-CAR T cells against h...
Autores principales: | Wang, Hezhi, Ye, Xueshuai, Ju, Yi, Cai, Ziqi, Wang, Xiaoxiao, Du, Pingping, Zhang, Mengya, Li, Yang, Cai, Jianhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210041/ https://www.ncbi.nlm.nih.gov/pubmed/32440140 http://dx.doi.org/10.2147/OTT.S247836 |
Ejemplares similares
-
Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo [Corrigendum]
Publicado: (2020) -
Folate Receptor-Alpha Targeted 7x19 CAR-γδT Suppressed Triple-Negative Breast Cancer Xenograft Model in Mice
por: Ye, Xueshuai, et al.
Publicado: (2022) -
Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma
por: Wang, Hezhi, et al.
Publicado: (2022) -
Anti-HER2 scFv-CCL19-IL7 recombinant protein inhibited gastric tumor growth in vivo
por: Zhang, Haiqiang, et al.
Publicado: (2022) -
Bacteria-free minicircle DNA system to generate integration-free CAR-T cells
por: Cheng, Chen, et al.
Publicado: (2019)